Aprea Therapeutics
APRE
#11121
Rank
NZ$5.94 M
Marketcap
NZ$0.42
Share price
-53.56%
Change (1 day)
-79.91%
Change (1 year)

EPS for Aprea Therapeutics (APRE)

EPS in 2026 (TTM): NZ-$1.87

According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$1.97. In 2025 the company made an earnings per share (EPS) of NZ-$3.62 an increase over its 2024 EPS that were of NZ-$4.35.

EPS history for Aprea Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.87-48.36%
2025NZ-$3.62-16.81%
2024NZ-$4.35
2022NZ-$177.70177.74%
2021NZ-$63.98-31.1%
2020NZ-$92.8670.91%
2019NZ-$54.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amedisys
AMED
NZ$4.77-341.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
NZ$2.76-239.81%๐Ÿ‡บ๐Ÿ‡ธ USA